小心非法“躺瘦”减肥药暗藏陷阱

Core Viewpoint - The article highlights the illegal sale of unapproved weight loss drugs in China, emphasizing the risks associated with such products and the ongoing efforts by authorities to combat this issue [1][2][3]. Group 1: Illegal Weight Loss Drugs - The Shanghai Railway Transportation Procuratorate reported a case involving the illegal sale of unapproved weight loss drugs, leading to a six-month prison sentence for the offender [1]. - The illegal products were marketed under enticing names and were found to be unapproved by the relevant authorities, posing significant health risks to consumers [1][2]. - Consumers reported adverse reactions such as dizziness, nausea, vomiting, and insomnia after using these drugs, with some requiring emergency medical treatment [1][2]. Group 2: Gray Market and Sales Tactics - The illegal weight loss drug market has developed a gray industry chain, with sellers using social media and encrypted communication to evade detection [2]. - Offenders purchase "three-no" (no production license, no quality guarantee, no business license) drugs at low prices (15-40 yuan) and resell them at inflated prices (100-200 yuan), generating substantial profits [2]. - The use of virtual numbers and overseas communication software complicates law enforcement efforts to dismantle these operations [2]. Group 3: Regulatory Response and Consumer Awareness - Authorities are increasing efforts to combat the production and sale of illegal drugs, collaborating with various departments to enhance drug safety governance [3]. - The illegal drugs are often disguised as regular cosmetics, making it challenging to regulate; thus, platforms are urged to strengthen monitoring and prevent such sales [3]. - Consumers are advised to pursue healthy weight loss methods through diet and exercise and to only use medications obtained through legitimate channels [3]. Group 4: Market Regulation and Misleading Advertising - The Beijing Market Supervision Administration has penalized a biotechnology company for misleading advertising during live-streaming sales, highlighting the need for accurate product representation [4]. - The regulation of "live-streaming review manipulation" has been incorporated into the enforcement framework, aiming to ensure truthful disclosure of product information [4].